BRCA1 and neoplasm: Although our BRCA1 knockdown and reconstitution studies in cell lines are consistent, reliance on in vitro models may not accurately reflect the in vivo scenario where cell–stromal interactions and immunoediting will significantly impact on tumour behaviour.